Blerina Resuli

5PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 15, 2026
CT-Derived Muscle and Adipose Tissue Characteristics and Survival in Advanced NSCLC Treated with First-Line Immunotherapy-Based Regimens.

|Dec 11, 2025
Distinct Clinical and Biological Features of Diffusely Metastatic Versus Bulky Localized Lung Cancer: Real-World Outcomes from a University Cancer Center in Germany.

Blerina Resuli, Julia Walter, Diego Kauffmann-Guerrero

|Aug 14, 2025
Treatment Strategies for First-Line PD-L1-Unselected Advanced NSCLC: A Comparative Review of Immunotherapy-Based Regimens by PD-L1 Expression and Clinical Indication.

Blerina Resuli, Diego Kauffmann-Guerrero, Maria Nieves Arredondo Lasso

|Apr 12, 2025
Toxicity Profile and Efficacy of Docetaxel Following Paclitaxel- or Pemetrexed-Platinum Chemotherapy Alone or in Combination With Immune Checkpoint Inhibitors in NSCLC Patients: A Single Institution Retrospective Analysis.

Blerina Resuli, Julia Walter, Diego Kauffmann-Guerrero

|Apr 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.

Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti

Pageof 1

Frequent Collaborators

3 joint publications

Jürgen Behr

1 joint publications

Marcelo V Negrao

1 joint publications

Haniel A Araujo

1 joint publications

Giuseppe Lamberti